Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (12996)	8/10/1998 11:22:00 PM
From: VLAD	Respond to of 23519

Kahuna, Thank you for the info regarding Invemed. Would it be reasonable to say that Invemed might just be privy to inside information regarding Vivus since they have worked so closely with the company in the past? Seems to me that towards the end of today's trading they were more than happy to absorb all the shares shorted towards the close. Does this mean that the investors behind Invemed plan to absorb all attacks at 5 3/4 regardless of costs and once the short interest realizes they can't crack this support level they will have to cover and end up absorbing loses for shorting at 5 3/4? How important is it to the short interest to break 5 3/4 and how much money are they willing to throw at 5 3/4 before other buyers step in and bid up the price and force the shorts to cover or take loses?

To: BigKNY3 who wrote (12996)	8/10/1998 11:48:00 PM
From: AlienTech	Read Replies (2) \| Respond to of 23519

>>A short-term gut feel based on previous price trends: VVUS will break 7 before ever reaching 5 1/4.<< Without news VVUS will break that 5 1/4 by end of this week.

To: BigKNY3 who wrote (12996)	8/11/1998 12:11:00 AM
From: Mkilloran	Respond to of 23519

BigKny3...thanks for your analysis on Vivus this weekend... It looks like Vivus continues to climb slowly up each week in script counts. The major activity is now supplying Astra and Janssen from the 3 lines at the old plant and four lines at the new plant. Vivus has the capacity fo 5 mill units a qtr now and can increase by 4 more lines with high level of automation...about 1 mill units a qtr per line in the new plant. Canada, China and Russia among others should be approved soon United Europe in the 1st qtr 1999.... IMO Vivus will start to rise from it's low price upward shortly... I have a lot more faith in Astra and Janssen's ability to sell this product with a greater success rate than Vivus themselves. Looking for a USA sales partner to be announce by the end of the 3rd qtr...and EPS to exceed the the analyst est of $0.09 this qtr.

To: BigKNY3 who wrote (12996)	8/11/1998 8:21:00 PM
From: BigKNY3	Read Replies (2) \| Respond to of 23519

BigKNY3 <<A short-term gut feel based on previous price trends: VVUS will break 7 before ever reaching 5 1/4.>> What I meant to say: "VVUS will break 7 before ever BREAKING 5 1/4. " Several points for VVUSers to consider: -Don't expect unbiased stock advice coming from VVUS employees. To you it's an investment.... to VVUS employees it's their job and livelihood...they better be optimistic. -The key to VVUS future price trends is NOT daily price movements, large block trades, analyst recommendations, improved profit margins, buyout rumors, production lines, news releases or even negative or positive Viagra news. In my opinion, VVUS price trends will continue to track US Rx specification levels. For VVUS to recover, MUSE Rxs must recover to their 1997 levels (15,800 per week). If I was a part-owner of VVUS (shareholders are!), I would be questioning what are the confirmed VVUS plans to accomplish this goal in 1998. I would be pretty upset if the answer was...we are waiting for Viagra to be removed from the market. Good luck!! BigKNY3 PS Suggestion: Isn't it time to combine the VVUS: Single Digits Thread with VVUS 1997/1998 and get a real dialogue going? Paranoia and name-calling would have to be discouraged. Is it possible?